4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000032
President and CEO acquired 8,498 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-07-27 | Exercise or conversion : show line 1 in the form | +8,498 | $11.77 | $99,990 | 601,524 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-07-27 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −8,498 | $11.77 | 2022-06-20 | 8,498 | 0 | D |
Loading xslF345X03/edgar.xml…